These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 16780708)

  • 21. Kawasaki disease.
    Harnden A; Tulloh R; Burgner D
    BMJ; 2014 Sep; 349():g5336. PubMed ID: 25230954
    [No Abstract]   [Full Text] [Related]  

  • 22. Revisiting steroids in the primary treatment of acute Kawasaki disease.
    Burns JC
    J Pediatr; 2006 Sep; 149(3):291-2. PubMed ID: 16939734
    [No Abstract]   [Full Text] [Related]  

  • 23. The Harada score in the US population of children with Kawasaki disease.
    Tewelde H; Yoon J; Van Ittersum W; Worley S; Preminger T; Goldfarb J
    Hosp Pediatr; 2014 Jul; 4(4):233-8. PubMed ID: 24986993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of immunoglobulin in the prevention of coronary artery aneurysms in Kawasaki disease].
    Chaker L; Drissa MA; Drissa H
    Tunis Med; 2009 Mar; 87(3):228-9. PubMed ID: 19537024
    [No Abstract]   [Full Text] [Related]  

  • 25. Kawasaki disease.
    Yamamoto LG
    Pediatr Emerg Care; 2003 Dec; 19(6):422-4. PubMed ID: 14676495
    [No Abstract]   [Full Text] [Related]  

  • 26. Macular oedema in Kawasaki syndrome.
    Garweg JG; Suter C; Aebi-Ochsner C; Villiger R
    Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):1101-4. PubMed ID: 22222924
    [No Abstract]   [Full Text] [Related]  

  • 27. Extensive coronary aneurysms with thrombosis in resistant Kawasaki disease.
    Sivakumar K; Pavithran S
    Pediatr Cardiol; 2013 Feb; 34(2):444-6. PubMed ID: 22427313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain natriuretic peptide levels in Kawasaki disease: a case report.
    Iwashima S; Ishikawa T; Ohzeki T
    Pediatr Int; 2009 Jun; 51(3):415-8. PubMed ID: 19500284
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiple giant succular and fusiform right and left coronary artery aneurysms after early and adequate treatment of atypical kawasaki disease with unusual presentation.
    Behjati-Ardakani M; Ferdosian F
    Acta Med Iran; 2014; 52(6):490-2. PubMed ID: 25130161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing Long-Term Cardiac Damage in Pediatric Patients With Kawasaki Disease.
    Williams K
    J Pediatr Health Care; 2017; 31(2):196-202. PubMed ID: 27592169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kawasaki disease in Jordan: demographics, presentation, and outcome.
    Al-Ammouri I; Al-Wahsh S; Khuri-Bulos N
    Cardiol Young; 2012 Aug; 22(4):390-5. PubMed ID: 22067065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kawasaki disease: part II. Complications and treatment.
    Bayers S; Shulman ST; Paller AS
    J Am Acad Dermatol; 2013 Oct; 69(4):513.e1-8; quiz 521-2. PubMed ID: 24034380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kawasaki disease in a 9-year old girl presenting with febrile cholestasis: case report and review of literature.
    Koca T; Aslan N; Akaslan Kara A; Pektas A; Ozen M; Akcam M
    Int J Rheum Dis; 2018 Nov; 21(11):2046-2049. PubMed ID: 26177575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease.
    Ebato T; Ogata S; Ogihara Y; Fujimoto M; Kitagawa A; Takanashi M; Ishii M
    J Pediatr; 2017 Dec; 191():140-144. PubMed ID: 29173297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting coronary aneurysms in Kawasaki disease.
    Gersony WM
    Am J Cardiol; 1998 May; 81(9):1162-4. PubMed ID: 9605060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation.
    Pagnini I; Marino A; Simonini G; Cimaz R
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S170. PubMed ID: 22410254
    [No Abstract]   [Full Text] [Related]  

  • 37. Rare refractory Kawasaki disease in an adolescent boy with cardiac and diffuse coronary artery involvement.
    Šileikienė R; Kudzytė J; Jankauskas A; Labanauskas L; Rakauskienė V; Jurkienė N; Kėvalas R
    Medicina (Kaunas); 2013; 49(7):341-5. PubMed ID: 24375247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A girl with extremely refractory Kawasaki disease: an instructive case with unusual course and outcome.
    Kossiva L; Karanassios E; Papadopoulos G; Karavanaki K
    Cardiol Young; 2012 Aug; 22(4):461-5. PubMed ID: 21933460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kawasaki disease: a clinical and epidemiological study of 70 children in Brazil.
    Magalhães CM; Vasconcelos PA; Pereira MR; Alves NR; Gandolfi L; Pratesi R
    Trop Doct; 2009 Apr; 39(2):99-101. PubMed ID: 19299294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin.
    Shirley DA; Stephens I
    Pediatr Infect Dis J; 2010 Oct; 29(10):978-9. PubMed ID: 20431427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.